Härtter, S.; Michaud, V.; Smith, M.K.; Dow, P.; Condon, G.; Desch, M.; Turgeon, J.
Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large Populations. Pharmaceuticals 2025, 18, 1453.
https://doi.org/10.3390/ph18101453
AMA Style
Härtter S, Michaud V, Smith MK, Dow P, Condon G, Desch M, Turgeon J.
Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large Populations. Pharmaceuticals. 2025; 18(10):1453.
https://doi.org/10.3390/ph18101453
Chicago/Turabian Style
Härtter, Sebastian, Veronique Michaud, Matt K. Smith, Pamela Dow, Gerald Condon, Michael Desch, and Jacques Turgeon.
2025. "Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large Populations" Pharmaceuticals 18, no. 10: 1453.
https://doi.org/10.3390/ph18101453
APA Style
Härtter, S., Michaud, V., Smith, M. K., Dow, P., Condon, G., Desch, M., & Turgeon, J.
(2025). Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large Populations. Pharmaceuticals, 18(10), 1453.
https://doi.org/10.3390/ph18101453
